The PHARMO Institute, part of Lumanity, delivers research insights into hemophilia A and B.

Our data is well-suited/ready for conducting hemophilia research with:

  • ~800 patients with hemophilia A and ~90 patients with hemophilia B with a hemophilia-related hospital admission/discharge or ambulatory consultation from 2013-2022

  • Unique linkages to clinical labs and pathology data to uncover specific blood-based results, genetic testing to gain a holistic understanding of hemophilia treatments and outcomes

  • Ability to address a wide range of RWE use cases from epidemiology and burden of disease, treatment pathways, drug safety and effectiveness, resource use and beyond

E-mail us at contact@lumanity.com to discuss your research needs.

Download our hemophilia one-pager

"*" indicates required fields

Sign me up to receive regular insights from Lumanity
By selecting this box, I consent to receive Lumanity marketing communications by email.
This field is for validation purposes and should be left unchanged.